BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 33743299)

  • 1. Machine learning for automated EEG-based biomarkers of cognitive impairment during Deep Brain Stimulation screening in patients with Parkinson's Disease.
    Geraedts VJ; Koch M; Contarino MF; Middelkoop HAM; Wang H; van Hilten JJ; Bäck THW; Tannemaat MR
    Clin Neurophysiol; 2021 May; 132(5):1041-1048. PubMed ID: 33743299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative Electroencephalography-Based Machine Learning Predicts Cognitive Deterioration After Subthalamic Deep Brain Stimulation.
    Geraedts VJ; Koch M; Kuiper R; Kefalas M; Bäck THW; van Hilten JJ; Wang H; Middelkoop HAM; van der Gaag NA; Contarino MF; Tannemaat MR
    Mov Disord; 2021 Oct; 36(10):2324-2334. PubMed ID: 34080712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.
    Markser A; Maier F; Lewis CJ; Dembek TA; Pedrosa D; Eggers C; Timmermann L; Kalbe E; Fink GR; Burghaus L
    J Neurol; 2015 Oct; 262(10):2275-84. PubMed ID: 26159102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of high-density EEG in patients with Parkinson's disease treated with deep brain stimulation.
    Buril J; Burilova P; Pokorna A; Balaz M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Dec; 164(4):366-370. PubMed ID: 32975241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive potential of preoperative electroencephalogram for neuropsychological change following subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Yakufujiang M; Higuchi Y; Aoyagi K; Yamamoto T; Abe M; Okahara Y; Izumi M; Nagano O; Yamanaka Y; Hirano S; Shiina A; Murata A; Iwadate Y
    Acta Neurochir (Wien); 2019 Oct; 161(10):2049-2058. PubMed ID: 31278598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Quantitative Electroencephalography Refine Preoperative Cognitive Assessment in Parkinson's Disease Patients Treated with Deep Brain Stimulation? A Follow-Up Study.
    Saleh C; Meyer A; Chaturvedi M; Beltrani S; Gschwandtner U; Fuhr P
    Dement Geriatr Cogn Disord; 2021; 50(4):349-356. PubMed ID: 34569496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.
    Gruber D; Calmbach L; Kühn AA; Krause P; Kopp UA; Schneider GH; Kupsch A
    J Neural Transm (Vienna); 2019 Mar; 126(3):309-318. PubMed ID: 30684055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mild cognitive impairment on outcome following deep brain stimulation surgery for Parkinson's disease.
    Abboud H; Floden D; Thompson NR; Genc G; Oravivattanakul S; Alsallom F; Swa B; Kubu C; Pandya M; Gostkowski M; Cooper S; Machado AG; Fernandez HH
    Parkinsonism Relat Disord; 2015 Mar; 21(3):249-53. PubMed ID: 25578289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroencephalography-based machine learning for cognitive profiling in Parkinson's disease: Preliminary results.
    Betrouni N; Delval A; Chaton L; Defebvre L; Duits A; Moonen A; Leentjens AFG; Dujardin K
    Mov Disord; 2019 Feb; 34(2):210-217. PubMed ID: 30345602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase lag index and spectral power as QEEG features for identification of patients with mild cognitive impairment in Parkinson's disease.
    Chaturvedi M; Bogaarts JG; Kozak Cozac VV; Hatz F; Gschwandtner U; Meyer A; Fuhr P; Roth V
    Clin Neurophysiol; 2019 Oct; 130(10):1937-1944. PubMed ID: 31445388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
    Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative EEG reflects non-dopaminergic disease severity in Parkinson's disease.
    Geraedts VJ; Marinus J; Gouw AA; Mosch A; Stam CJ; van Hilten JJ; Contarino MF; Tannemaat MR
    Clin Neurophysiol; 2018 Aug; 129(8):1748-1755. PubMed ID: 29887401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson's Disease.
    Nassery A; Palmese CA; Sarva H; Groves M; Miravite J; Kopell BH
    Curr Neurol Neurosci Rep; 2016 Oct; 16(10):87. PubMed ID: 27539167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleus basalis of Meynert neuronal activity in Parkinson's disease.
    Lee DJ; Milosevic L; Gramer R; Sasikumar S; Al-Ozzi TM; De Vloo P; Dallapiazza RF; Elias GJB; Cohn M; Kalia SK; Hutchison WD; Fasano A; Lozano AM
    J Neurosurg; 2019 Feb; 132(2):574-582. PubMed ID: 30797189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Quantitative EEG to the Diagnosis of Early Cognitive Impairment in Patients With Idiopathic Parkinson's Disease.
    Guner D; Tiftikcioglu BI; Tuncay N; Zorlu Y
    Clin EEG Neurosci; 2017 Sep; 48(5):348-354. PubMed ID: 27491643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive profile as a predictor of the long-term outcome after deep brain stimulation in Parkinson's disease.
    Park KW; Jo S; Kim MS; Choi N; Jeon SR; Park HK; Kwon KY; Lee CS; Chung SJ
    J Neurol Sci; 2020 Oct; 417():117063. PubMed ID: 32777578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning trained with quantitative susceptibility mapping to detect mild cognitive impairment in Parkinson's disease.
    Shibata H; Uchida Y; Inui S; Kan H; Sakurai K; Oishi N; Ueki Y; Oishi K; Matsukawa N
    Parkinsonism Relat Disord; 2022 Jan; 94():104-110. PubMed ID: 34906915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of EEG slowing with cognitive domains in nondemented patients with Parkinson's disease.
    Zimmermann R; Gschwandtner U; Hatz F; Schindler C; Bousleiman H; Ahmed S; Hardmeier M; Meyer A; Calabrese P; Fuhr P
    Dement Geriatr Cogn Disord; 2015; 39(3-4):207-14. PubMed ID: 25591733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Yágüez L; Costello A; Moriarty J; Hulse N; Selway R; Clough C; Samuel M; Ashkan K
    J Clin Neurosci; 2014 Mar; 21(3):445-50. PubMed ID: 24231557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An SBM-based machine learning model for identifying mild cognitive impairment in patients with Parkinson's disease.
    Zhang J; Li Y; Gao Y; Hu J; Huang B; Rong S; Chen J; Zhang Y; Wang L; Feng S; Wang L; Nie K
    J Neurol Sci; 2020 Nov; 418():117077. PubMed ID: 32798842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.